BIRC2 blockade facilitates immunotherapy of hepatocellular carcinoma

Table 1 Association of BIRC2 expression with clinicopathological features in HCC patients

	Total (n = 765)	BIRC2 low (n = 539)	BIRC2 high (n = 226)	P
Gender				0.433
Male	677	481	196
Female	88	58	30
Age, y				0.058
≥ 49	378	255	123
< 49	387	284	103
Tumor size				0.071
< 5 cm ≥ 5 cm	194 571	157 382	37 189
NIK				< 0.001
Low	227	116	111
High	558	423	135
HLA-ABC				< 0.001
Low	263	130	133
High	502	409	93
Vascular invasion				0.063
Absent	620	445	175
Present	145	94	51

ISSN: 1476-4598